Johnson Chemical Pharmaceutical Works Co., Ltd.

Taipei Exchange 4747.TWO

Johnson Chemical Pharmaceutical Works Co., Ltd. Free Cash Flow Yield on January 14, 2025: 3.47%

Johnson Chemical Pharmaceutical Works Co., Ltd. Free Cash Flow Yield is 3.47% on January 14, 2025, a -3.88% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. 52-week high Free Cash Flow Yield is 3.74% on August 05, 2024, which is 7.86% above the current Free Cash Flow Yield.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. 52-week low Free Cash Flow Yield is 3.13% on November 01, 2024, which is -9.79% below the current Free Cash Flow Yield.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 3.45%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Taipei Exchange: 4747.TWO

Johnson Chemical Pharmaceutical Works Co., Ltd.

CEO Mr. Pai-Hsiung Huang
IPO Date June 28, 2012
Location
Headquarters No. 77 and No.79, Sanhe Road
Employees 167
Sector Health Care
Industries
Pharmaceuticals
Description

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorporated in 1959 and is based in New Taipei City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email